Drugs / calcium leucovorin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01035385 | Sep 2009 → Oct 2012 | metastasis from malignant tumor of colon | Guangdong Provincial People's Hospital | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 0 | NCT05590117 Comparator | Oct 2022 → Oct 2023 | colorectal cancer, mucositis, peripheral neuropathy | Tanta University | Unknown | No outcome recorded |
| Phase 2 | NCT04141995 Background | Feb 2021 → May 2025 | pancreatic adenocarcinoma | University of Nebraska | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | calcium leucovorin | “Oxaliplatin, Fluorouracil, calcium leucovorin” NCT05590117 ↗ |
| Route | Intravenous | “calcium leucovorin:200mg/m2 ivgtt” NCT01035385 ↗ |